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eply
e would like to thank Dr. Taggart for his interest in our study
1) and his thoughtful comments. We would like to address each
oint separately.
Dr. Taggart states that: “Rather than presenting total mortality,
hich is obligatory for reporting of surgical outcomes, they present
he incidence of cardiac death, according to the Academic
esearch Consortium definition. This sets a dangerous precedent,
s cardiac mortality is a less objective outcome measure than total
ortality, and a better compromise would be to present both;
resentation of total mortality should, however, remain mandatory.”
The main aim of the DELFT registry (1) was to assess
ong-term clinical outcome among patients undergoing percuta-
eous coronary intervention for unprotected left main coronary
rtery disease. Cardiac death is reported because we think this
arameter reflects the direct effect of the interventional treatment
n patients’ prognosis. Cardiac death is reported in concordance
ith the Academic Research Consortium definition and is specific
or and directly related to the treatment under investigation (2).
ccording to the Academic Research Consortium definition, “all
eaths are considered cardiac unless an unequivocal non-cardiac
ause can be established.” Moreover, “any unexpected death even
n patients with coexisting potentially fatal non-cardiac disease
e.g., cancer, infection) is classified as cardiac.” For this reason, we
hink that cardiac mortality should not be considered less objective
ut rather a more specific outcome measure. However, we do
ccept that concurrent reporting of total mortality adds additional
nformation. In the DELFT registry (n  358), the incidence of
otal death at 1 and 3 years was 7% (25 patients vs. 24 cardiac
eaths) and 11.2% (40 patients vs. 33 cardiac deaths), respectively.
n elective patients (n 288), total death at 1 and 3 years was 3.8%
11 patients vs. 11 cardiac deaths) and 8.3% (24 patients vs. 18 cardiac
eaths). These results are in line with previous reports (3–5).
The second point made by Dr. Taggart is: “During the period
f the study, 680 patients underwent coronary artery bypass
rafting in the 7 participating centers. There are no data to inform
hether coronary artery bypass grafting patients differed system-
tically from those undergoing stenting in terms of complexity of
eft main disease, severity of concomitant multivessel coronary
rtery disease, existence of comorbid conditions, or, indeed, how
he decision was made as to which intervention patients would
eceive.”
We would like to point out that we reported the number of
oronary artery bypass grafting (CABG) procedures performed
oncomitantly to give to the reader an idea of the surgical
rocedural volume in the participating centers over the same time
eriod. It is beyond the scope of the DELFT registry to provide a
omparison between CABG and percutaneous coronary interven-
ion, and, therefore, demographic data relevant to CABG cases
ere not provided. We do intend to address this question with
ubsequent analyses.The third point made by Dr. Taggart is that “there is no explicit
tatement as to whether all interventions were decided by a
ultidisciplinary team including a surgeon. The increasing ten-
ency to report interventional treatments being based on ‘patient
r physician preference’ is both inadequate and inappropriate
ecause it reduces the likelihood that patients will receive impartial
nformation and, as a consequence, will not ensure that there is,
herefore, real patient choice and genuine informed consent.
nless a patient is clearly unfit or unwilling to pursue a surgical
ption, discussion of all interventions by a multidisciplinary team
hould be a minimum standard of care.”
In response, we would like to note that, as previously described
y our group (6), the current standard of care for patients with
ignificant unprotected left main coronary artery disease is to have
hem evaluated by both an interventional cardiologist and cardiac
urgeon and to reach consensus regarding optimal management. In
aking this decision, the hemodynamic conditions, lesion, and
essel characteristics; presence of comorbidities; quality of arterial
nd/or venous conduits for grafting; and patient and/or referring
hysician preference should be considered. This can be done at a
ultidisciplinary conference or by direct consultation in the acute
etting and is standard practice at the contributing institutions in
ur registry.
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